Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$800M |
| 2 |
NVIDIA
NVDA
|
+$304M |
| 3 |
Broadcom
AVGO
|
+$261M |
| 4 |
Linde
LIN
|
+$237M |
| 5 |
JPMorgan Chase
JPM
|
+$208M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Costco
COST
|
+$656M |
| 2 |
Netflix
NFLX
|
+$632M |
| 3 |
Tesla
TSLA
|
+$474M |
| 4 |
Procter & Gamble
PG
|
+$428M |
| 5 |
Micron Technology
MU
|
+$332M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.04% |
| 2 | Healthcare | 15.34% |
| 3 | Industrials | 11.14% |
| 4 | Consumer Discretionary | 10.86% |
| 5 | Financials | 10.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1626
Schwab Intermediately-Term US Treasury ETF
SCHR
$13.1B
| $3.23M | 0.01% |
129,700
+84,700
| +188% | +$2.12M |
2025 Q1
4 quarters
|
|
1627
HDFC Bank
HDB
$115B
| $3.22M | 0.01% |
+129,300
| New | +$4.02M |
2026 Q1
0 quarters
|
|
1628
Grayscale Bitcoin Trust
GBTC
$12.3B
| $3.22M | 0.01% |
60,950
-59,150
| -49% | -$3.52M |
2025 Q2
3 quarters
|
|
1629
First Trust Morningstar Dividend Leaders Index Fund
FDL
$7.65B
| $3.22M | 0.01% |
63,300
+24,400
| +63% | +$1.19M |
2025 Q1
4 quarters
|
|
1630
Resolute Holdings Management
RHLD
$924M
| $3.21M | 0.01% |
19,800
+7,100
| +56% | +$1.29M |
2025 Q3
2 quarters
|
|
1631
Nouveau Monde Graphite
NMG
$346M
| $3.21M | 0.01% |
1,433,023
+1,321,523
| +1,185% | +$3.23M |
2025 Q3
2 quarters
|
|
1632
South Plains Financial
SPFI
$797M
| $3.2M | 0.01% |
76,400
+700
| +0.9% | +$28.9K |
2024 Q3
6 quarters
|
|
1633
Grupo SIMEC
SIM
| $3.19M | 0.01% |
206,824
-2,146
| -1% | -$65.5K |
2013 Q2
51 quarters
|
|
1634
Vaxcyte
PCVX
$10.6B
| $3.18M | 0.01% |
54,734
-10,477
| -16% | -$569K |
2024 Q4
5 quarters
|
|
1635
Autolus Therapeutics
AUTL
$482M
| $3.17M | 0.01% |
2,299,499
-805,905
| -26% | -$1.22M |
2022 Q2
15 quarters
|
|
1636
Kyverna Therapeutics
KYTX
$395M
| $3.17M | 0.01% |
367,492
+189,593
| +107% | +$1.58M |
2024 Q4
5 quarters
|
|
1637
Establishment Labs
ESTA
$1.84B
| $3.17M | 0.01% |
+55,800
| New | +$3.81M |
2026 Q1
0 quarters
|
|
1638
Costamare Bulkers Holdings
CMDB
$505M
| $3.16M | ﹤0.01% |
204,439
+66,390
| +48% | +$1.12M |
2025 Q2
3 quarters
|
|
1639
First Trust Natural Gas ETF
FCG
$669M
| $3.16M | ﹤0.01% |
99,800
+89,200
| +842% | +$2.41M |
2025 Q1
4 quarters
|
|
1640
Loar Holdings
LOAR
$5.82B
| $3.16M | ﹤0.01% |
55,100
-33,500
| -38% | -$2.26M |
2025 Q4
1 quarter
|
|
1641
XPLR Infrastructure LP
XIFR
$978M
| $3.15M | ﹤0.01% |
297,000
-385,700
| -56% | -$3.97M |
2025 Q3
2 quarters
|
|
1642
Mechanics Bancorp
MCHB
$3.16B
| $3.15M | ﹤0.01% |
213,474
-88,626
| -29% | -$1.31M |
2025 Q3
2 quarters
|
|
1643
Realty Income
O
$51.3B
| $3.15M | ﹤0.01% |
+51,444
| New | +$3.22M |
2026 Q1
0 quarters
|
|
1644
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$12.9B
| $3.15M | ﹤0.01% |
33,500
+29,700
| +782% | +$2.85M |
2025 Q4
1 quarter
|
|
1645
Yeti Holdings
YETI
$2.9B
| $3.13M | ﹤0.01% |
85,500
+43,900
| +106% | +$1.93M |
2025 Q2
3 quarters
|
|
1646
U.S. Small Cap Value Portfolio ETF Class Shares
DFSV
$8.06B
| $3.13M | ﹤0.01% |
+89,200
| New | +$3.15M |
2026 Q1
0 quarters
|
|
1647
BCB Bancorp
BCBP
$253M
| $3.1M | ﹤0.01% |
345,194
+18,000
| +6% | +$147K |
2015 Q4
41 quarters
|
|
1648
KVH Industries
KVHI
$120M
| $3.1M | ﹤0.01% |
345,515
+62,407
| +22% | +$436K |
2013 Q2
51 quarters
|
|
1649
Xperi
XPER
$254M
| $3.08M | ﹤0.01% |
550,183
-41,200
| -7% | -$239K |
2022 Q4
13 quarters
|
|
1650
Invesco Aerospace & Defense ETF
PPA
$7.42B
| $3.07M | ﹤0.01% |
18,500
+12,400
| +203% | +$2.17M |
2025 Q3
2 quarters
|
|
Similar funds
Renaissance Technologies's Q1 2026 Portfolio in Review
As of Q1 2026, Renaissance Technologies held 3,809 positions worth $63.9B, down 0.82% from $64.5B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Renaissance Technologies's Q1 2026 filing shows 624 new, 1,320 increased, 1,262 reduced and 596 closed positions. Its largest new stake was Apple: 3,075,638 shares worth $781M. The largest sale was Costco, an estimated $656M.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 21% a quarter earlier, followed by Healthcare and Industrials.
- Renaissance Technologies's largest Q1 2026 buy was Apple: 3,075,638 shares worth $781M.
- Renaissance Technologies added most to NVIDIA in Q1 2026, an estimated $304M increase.
- Renaissance Technologies's biggest Q1 2026 reduction was Costco, cutting an estimated $656M.
- Renaissance Technologies fully exited Procter & Gamble in Q1 2026, selling an estimated $428M.
- Renaissance Technologies's ten largest holdings make up 11% of its $63.9B portfolio in Q1 2026.
- Renaissance Technologies opened 624 new positions and closed 596 in Q1 2026.
- Renaissance Technologies's portfolio value fell 0.82% quarter-over-quarter to $63.9B.
Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.